EI
IONS icon

Ethic Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Ethic Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
+31,679
New +$2.38M 0.03% 447

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ethic Inc's IONS Position: Q2 2026 in Review

Ethic Inc opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 31,679 shares worth $2.51M. The stake represents 0.03% of the portfolio and ranks #447 among its holdings.

513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Ethic Inc held 31,679 shares of Ionis Pharmaceuticals worth $2.51M as of Q2 2026.
  • Ionis Pharmaceuticals was a new Ethic Inc position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.03% of Ethic Inc's portfolio in Q2 2026, its #447 holding.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.